Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976806 · ClinicalTrials.gov registry record · Phase 2
The Effects of DHA on Periodontitis
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT01976806 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 55 participants.
The verdict
NCT01976806, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether docosahexaenoic acid (DHA) is effective in the treatment of periodontitis in adults.
Interventions
- DRUG Aspirin
- DRUG Docosahexaenoic acid
- DRUG Placebo (for Docosahexaenoic acid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01976806
The ClinicalTrials.gov registry entry for NCT01976806 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Aspirin is the first listed.
NCT01976806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01976806 about?
NCT01976806 is a clinical study titled "The Effects of DHA on Periodontitis". The purpose of this study is to determine whether docosahexaenoic acid (DHA) is effective in the treatment of periodontitis in adults.
What is the current status of trial NCT01976806?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2009-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01976806?
The interventions under investigation include: Aspirin (DRUG), Docosahexaenoic acid (DRUG), Placebo (for Docosahexaenoic acid) (DRUG).
Who is sponsoring clinical trial NCT01976806?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.